Table 1.
Group Variable |
Group (P) (n = 30) |
Group (E) (n = 30) |
Group (D) (n = 30) |
Group (D/E) (n = 30) |
P value |
---|---|---|---|---|---|
Age (years) | 46.50 ± 8.74 | 45.26 ± 7.50 | 48.36 ± 9.80 | 47.50 ± 10.14 | 0.455 |
Male/Female (n) | 15/15 | 17/13 | 18/12 | 16/14 | 0.471 |
Weight (kg) | 81.23 ± 13.24 | 82.53 ± 12.90 | 80.60 ± 13.37 | 78.83 ± 16.78 | 0.794 |
Height (cm) | 167.46 ± 8.50 | 165.53 ± 7.71 | 165.40 ± 8.21 | 165.00 ± 9.63 | 0.478 |
ASA (n) | |||||
I | 18 | 18 | 17 | 15 | 0.36 |
II | 7 | 6 | 9 | 10 | 0.42 |
III | 5 | 6 | 4 | 5 | 0.23 |
Duration of surgery (min) | 109.9 ± 10.8 | 115.7 ± 9.8 | 113.2 ± 13.7 | 117.8 ± 9.7 | 0.65 |
Data are presented as Mean ± SD or number (n)
Placebo group (P), Etoricoxib group (E), Duloxetine group (D), Duloxetine/Etoricoxib group (D/E). Data were analyzed using ANOVA test with post hoc test (Bonferroni) and chi square test